Portrait elbion discovers and develops new small molecule drugs. Central nervous system diseases and immunology disorders with high unmet medical need and high commercial potential are at the center of elbion's products pipeline, which covers all stages from early "hits" to advanced clinical projects.
Top
Kontakt
Druckansicht
PDF-Ansicht
Firma weiterempfehlen
